On Friday, Central Pacific Financial Corp. (NYSE:CPF)’s shares declined -5.85% to $22.37.
Central Pacific Financial Corp. (CPF) declared the pricing of the formerly declared underwritten secondary offering by ACMO-CPF, L.L.C. and Carlyle Financial Services Harbor, L.P. of 3,000,000 shares of the Company’s common stock. Right away following completion of the offering, each selling shareholder will beneficially own about 8.78% of the Company’s outstanding common stock. All of the shares are being sold by the selling shareholders, and the selling shareholders will receive all of the net proceeds from the offering.
Citigroup is acting as sole underwriter for the common stock offering.
The offering is predictable to close on or about June 10, 2015, subject to customary closing conditions.
Central Pacific Financial Corp. operates as the holding company for Central Pacific Bank that provides commercial banking products and services to businesses, professionals, and individuals in Hawaii. The company operates in three segments: Banking Operations, Treasury, and All Others. It offers various deposit products and services, counting personal and business checking and savings accounts, money market accounts, and time certificates of deposit.
PHH Corporation (NYSE:PHH)’s shares gained 2.45% to $27.13.
PHH Corporation (PHH) declared recently that it has launched a sweepstakes that will give consumers the opportunity to win up to a grand total of $50,000 toward home improvements.
The 2015 Move & Improve Sweepstakes is sponsored by the PHH Home Loans family of brands - comprised of PHH Home Loans, Coldwell Banker Home Loans, Cartus Home Loans, NE Moves Mortgage, Axiom Financial, Sunbelt Lending Services, Princeton Capital, First Capital and Mortgage California. All customers who close a residential purchase loan with any of the nine brands between June 1 and September 30, 2015, will automatically be entered to win one of eight prizes. Consumers 18 or older may also enter the sweepstakes via mail-in postcard, as no purchase is necessary to enter. The prizes comprise:
- Grand Prize: $25,000 cash
- Second Prize: $10,000 cash
- Six (6) Third Prizes of $2,500 Home Depot® gift cards
PHH Corporation, through its auxiliaries, provides outsourced mortgage banking services to financial institutions and real estate brokers in the United States. The company operates through two segments, Mortgage Production and Mortgage Servicing. The Mortgage Production segment provides private-label mortgage services to financial institutions and real estate brokers; and originates and sells mortgage loans.
At the end of Friday’s trade, Advaxis, Inc. (NASDAQ:ADXS)‘s shares dipped -0.35% to $28.42.
Advaxis, Inc. (ADXS) declared the clearance of the Investigational New Drug (IND) application by the United States Food and Drug Administration (FDA) to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation’s (INCY) investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.
In February 2015, Advaxis and Incyte reached a non-exclusive clinical trial partnershipagreement to evaluate the combination of ADXS-HPV with epacadostat for the treatment of cervical cancer. The projected Phase 2 protocol is designed as a multicenter, open-label, preoperative window-study designed to evaluate the safety and efficacy of ADXS-HPV as monotherapy and in combination with epacadostat in about 30 patients with Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer. The results will be used to determine whether further clinical development of this combination is warranted.
Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. The Lm-LLO immunotherapy platform technology stimulates the immune system to induce antigen-specific anti-tumor immune responses involving innate and adaptive arms of the immune system by inhibiting the T-cells, tregs, and myeloid-derived suppressor cells, and MDSC to promote immunologic tolerance of cancer cells in the tumor. Its lead product ADXS-HPV, an Lm-LLO immunotherapy product candidate used for the treatment of human papilloma virus (HPV) associated cancers, accomplished its Phase II study. The company is also developing ADXS-PSA, an Lm-LLO immunotherapy product candidate designed to target the PSA antigen associated with prostate cancer; and ADXS-HER2, an Lm-LLO immunotherapy product candidate for the treatment of Her2 expressing cancers, counting human and canine osteosarcoma, breast, gastric, and other cancers.
EVINE Live Inc (NASDAQ:EVLV), ended its Friday’s trading session with -2.61% loss, and closed at $2.98.
EVINE Live Inc (EVLV) declared that Nancy O’Dell, the Emmy Award winning co-host of Entertainment Tonight, will premiere an exclusive fashion line during EVINE Live’s September 12th Fashion Day event. Known for her fashion sense and style, O’Dell has developed a sophisticated woman’s sportswear collection inspired by her personal wardrobe.
Premiering during EVINE Live’s Fashion Day event on September 12, O’Dell’s collection combines regal colors with elegant silhouettes and updated design twists to make a striking statement. The collection embodies the bold yet sophisticated looks for which she is known both on and off the Red Carpet. Exclusively accessible on EVINE Live, the collection comprises a wide array of styles in season-perfect colors and prints, counting dresses, jackets, jumpsuits, tops and bottoms.
EVINE Live Inc. operates as a digital commerce company in the United States. The company markets, sells, and distributes products to consumers through TV, online, mobile, and social media in the merchandise categories of home, beauty, health and fitness, fashion and accessories, jewelry and watches, and consumer electronics. It has access to about 88 million cable and satellite television homes, in addition to accessible through live streaming at evine.com.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
